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Is abdominal aortic aneurysm repair appropriate in
oxygen-dependent chronic obstructive pulmonary
disease patients?
Christopher N. Compton, MD, Ellen D. Dillavou, MD, Maureen K. Sheehan, MD,
Robert Y. Rhee, MD, and Michel S. Makaroun, MD, Pittsburgh, Pa
Background: The life expectancy of patients with oxygen-dependent chronic obstructive pulmonary disease (COPD) is
significantly reduced, but the risk of any intervention is considered prohibitive. However, severe COPDmay increase the
risk of abdominal aortic aneurysm (AAA) rupture. We reviewed our experience with AAA repair in oxygen-dependent
patients to determine whether operative risk and expected long-term survival justify surgical intervention.
Methods:A retrospective review of 44 consecutive patients with oxygen-dependent COPD undergoing AAA repair over an
8-year period was performed. Information was recorded for survival, length of follow-up, patient age, medical
comorbidities, pulmonary function tests, and operative approach. Survival data were analyzed by Kaplan-Meier curves
and compared with published cohorts of oxygen-dependent patients and the natural history of untreated aneurysms.
Results: Twenty-four patients underwent endovascular aneurysm repair (EVAR), and 20 underwent open procedures (14
retroperitoneal and 6 transabdominal). The mean AAA diameter was 6.1 cm (range, 5-9.5 cm). The mean age was 71.4
years, and 82% of patients were male. Operative mortality was 0%. The mean length of stay was 11.2 days for open
procedures and 4.3 days for EVAR (significantly longer than that for standard-risk patients). The mean survival time was
37.9 months (range, 2-91 months). Preoperative medical comorbidities, type of repair, and pulmonary function tests
were not predictive of survival. Postoperative morbidity was significantly higher with open repair. Long term survival was
comparable to historical series of the natural history of O2 dependent patients without AAA but better than untreated 6 cm
AAA cohorts. At 42 months, almost 50% of patients in our study group were still alive, compared to 20% survival at 34
months for those with untreated 6 cm AAAs.
Conclusions: It is reasonable to continue to offer AAA repair to home oxygen–dependent COPD patients who are
ambulatory and medically optimized and who are without untreated coronary artery disease. Although EVARmay be the
most suitable treatment for oxygen-dependent COPD patients, our results show that even open repair may be safely
performed in this population, with acceptable results. ( J Vasc Surg 2005;42:650-3.)A significant comorbidity associated with poor out-
come for any major surgical procedure has been depen-
dency on home oxygen and severe chronic obstructive
pulmonary disease (COPD).1,2 In addition, this condition
is known to be associated with an increased prevalence of
abdominal aortic aneurysm (AAA)3,4 and is an independent
predictor of AAA rupture.5 Thus, patients with severe
COPD and AAA are at an increased risk of rupture and have
an apparently higher risk for any type of intervention. The
purpose of this study was to determine whether the long-
term survival of patients with home oxygen–dependent
COPD undergoing AAA repair (compared with the natural
history of AAA and home oxygen dependence) justifies
intervention.
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650METHODS
Study group. All patients with home oxygen–dependent
COPD who underwent elective infrarenal AAA repair in
the last 11 years at the University of Pittsburgh Medical
Center were retrospectively reviewed. From 1992 to 2003,
44 consecutive patients were identified at our institution.
These patients were on home oxygen before surgery and
satisfied one or more of the following criteria: a room air
PO2 of 60 mm Hg or less, PaCO2 greater than 45 mm Hg,
forced expiratory volume at 1 second (FEV1) less than 50%
of predicted, and/or forced vital capacity (FVC) less than
75% of predicted.
Follow-up intervals, survival, preoperative comorbidi-
ties, method of repair, length of stay, intensive care unit
(ICU) use, and postoperative complications were recorded
for all patients. This group was stratified with separate
Kaplan-Meier curves. Data were compared via the log-rank
test with respect to operative approach to determine
whether this was predictive of outcome. The research pro-
tocol was reviewed and approved by the Institutional Re-
view Board of the University of Pittsburgh.
Control groups. The long-term survival rate of our
cohort was compared with that of two historical control
groups from previous reports by using Kaplan-Meier curve
estimates. The first control group represented the natural
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COPD patients.6 The second comparison group included
untreated AAAs in patients who were deemed unfit for
intervention or who refused treatment.7
Clinical pathway. The previously reported clinical
pathway8 from our institution has been used at our institu-
tion since 1993 and was incorporated in the perioperative
care of all patient groups. To summarize briefly, the path-
way consisted of limited perioperative intravenous fluid
administration, epidural analgesia, early extubation, ag-
gressive pulmonary toilet, and early ambulation. The path-
way was modified in our current study group slightly by
admitting essentially all patients with oxygen-dependent
COPD to the ICU after open repair for overnight observa-
tion. After endovascular aneurysm repair (EVAR), ICU
admission was used only for respiratory compromise. All
patients underwent preoperative pulmonary function test-
ing and outpatient medical optimization by a pulmonary
specialist. Patients were required to be ambulatory and have
no or minimal evidence of reversible ischemia on noninva-
sive cardiac testing before they were offered therapy.
RESULTS
Of the 44 patients in the study group, 24 underwent
EVAR and 20 underwent direct, open procedures. Four-
teen of the 20 patients who underwent an open operation
had the repair performed by using a limited left flank
retroperitoneal approach. Twenty-three patients under-
went general anesthesia: 20 open and 3 EVAR. Twenty-
one patients underwent epidural anesthesia alone. The
mean AAA diameter was 6.1 cm (range, 5-9.1 cm). The
median AAA diameter was 6.0 cm (25th percentile, 5.5 cm;
75th percentile, 6.7 cm). The mean age of the patients was
71.4 years; 82% of the patients were male. All patients had
PaO2 less than 60 mm Hg and PaCO2 greater than 45 mm
Hg on room air before surgery, and 79% had FEV1 less than
50% and FVC less than 75% of predicted on pulmonary
function testing.
The average length of stay was 11.2 days for open AAA
repair vs 4.3 days for EVAR (P .004). Eighteen (90%) of
the 20 open repair patients were admitted to the ICU after
surgery as part of the routine pathway, compared with 4
(17%) of 24 for the EVAR group (P .001). Overall, 30%
of patients required longer than 24 hours in the ICU.
Operative mortality was 0%. The mean actuarial survival
was 37.9 months (range, 2-91 months), and the mean
follow-up was 23.7 months. There was no difference in
survival for open vs endovascular approaches (Figure 1).
Five-year survival was 30%; this is in contrast to a 5-year
survival of 66% for the general population undergoing
elective AAA repair.9 Age older than 80 years seemed to
decrease survival. Postoperative morbidity was predictably
higher in the open group than in the EVAR group (Table).
However, the long-term survival for oxygen-dependent
patients undergoing AAA repair compared favorably to the
natural history of home oxygen dependence10 (Figure 2.
The long-term survival of home oxygen–dependent
COPD patients undergoing AAA repair also comparedfavorably to the natural history of untreated 6-cm aneu-
rysms.11 Most (80%) of the patients with untreated 6-cm
AAAs either experienced ruptured aneurysms or died
within 34 months. At 42 months, almost 50% of patients in
our study group were still alive (Figure 3).
DISCUSSION
The decision to offer elective repair to patients with
AAAs hinges on the estimate of the risks and benefits
involved. One must weigh the risk of rupture and almost
certain death12 after such an event with the risks associated
with elective repair. Most estimates of AAA rupture risk
have been based on aneurysm size.13 The natural history of
AAA is still unclear, but recent reports have elucidated
some of the trends.14,15 It is clear that large AAA (6 cm)
poses a significant threat of rupture, and repair should not
be denied in good-risk patients.16 The difficult decision
stems from determining whether a patient with a significant
Fig 1. Kaplan-Meier survival analysis for open vs endovascular
(Endo) repair of abdominal aortic aneurysm in oxygen-dependent
chronic obstructive pulmonary disease patients. NS, Not signifi-
cant.
Table 1. Post-operative morbidity
Morbidity Overall Open Endo
Respiratory Failure 5/44 (11%) 3/20 2/24
Atrial fibrillation 3/44 (7%) 3/20 0/24
Pneumonia 4/44 (9%) 3/20 1/24
Reintubation 4/44 (9%) 3/20 1/24
GI Bleed 1/44 (2%) 1/20 0/24
Urinary Retention 3/44 (7%) 1/20 2/24
Myocardial Infarction 0/44 (0%) 0/20 0/24
Renal Failure 1/44 (2%) 1/20 0/24
ARDS 1/44 (2%) 1/20 0/24
Total 22 16 6morbidity such as COPD would benefit from intervention.
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may provide further information regarding rupture risk by
using a more physiologic predictor.17,18 However, these
techniques have not yet been correlated clinically. Until
that time, a risk analysis of the patient’s comorbidities must
be performed to justify the risks involved in the planned
intervention.
Clinical factors, such as female sex19 and pulmonary
disease (COPD),20,21 have been known to increase rupture
risk at a given size, but the exact influence has been difficult
to quantitate. A University of Michigan study found a
Fig 2. Kaplan-Meier survival analysis of oxygen-dependent chronic
obstructive pulmonary disease (COPD) patients undergoing abdom-
inal aortic aneurysm (AAA) repair vs the natural history of oxygen-
dependent COPD.
Fig 3. The Kaplan-Meier survival curve is shown for oxygen-
dependent chronic obstructive pulmonary disease patients under-
going abdominal aortic aneurysm (AAA) repair vs the natural
history of untreated 6-cm AAAs and the natural history of home
oxygen dependence.5-year predicted AAA rupture rate of 34% in patients withCOPD, compared with only 2% in patients without this
condition.
Unfortunately, however, this very group of patients
who are at increased risk for rupture and death from AAA
disease are often denied treatment because of the perceived
increased risk with surgery. Several studies have demon-
strated increased morbidity and mortality after AAA repair
in patients with COPD.22,23 It has been suggested that an
increased risk of pulmonary complications is associated
with a FEV1 or FVC of less than 70% of the predicted value
or a ratio of FEV1 to FVC of less than 65%.
24 COPD is also
associated with increased mortality after coronary artery
bypass grafting25 and laparotomy.26
Hence, patients with COPD not only are at increased
risk for rupture, but also seem to have an increased risk for
intervention. However, most of the literature regarding the
risk of severe COPD is written in the setting of lung-
reduction surgery or thoracotomy.27,28
Ultimately, the risk of intervention depends not only
on the method of repair used, but also on the comorbidities
present in an individual patient. Of course, the life expect-
ancy of the patient is also important to judge the length of
protection afforded by the aneurysm repair and whether it
will justify the risks involved in the intervention.
The risk of AAA rupture in patients who are deemed
unsuitable for therapy seems to be higher than that for
standard-risk patients who are followed up prospectively. A
Veterans Affairs Cooperative study that followed up AAA
patients who were deemed unfit for or refused repair dem-
onstrated a significant risk of rupture. The annual risk of
rupture for aneurysms 5.5 to 5.9 cm in diameter was almost
10% and was 19% for those with diameters 6.5 to 6.9 cm.
The all-cause mortality was 29.8% at 1 year, 55.5% at 2
years, and 75.4% at 3 years in this population of patients
who were denied AAA repair.29
Our current study and our previous report30 show a
very lowmortality andmorbidity in such patients after AAA
repair. It is interesting to note that a recent review also
demonstrated that home oxygen use was not found to be
predictive of poor outcome in COPD patients undergoing
elective AAA repair.31 With no operative mortality, a mean
survival of longer than 3 years, and an average aneurysm
diameter of more than 6 cm, our long-term results com-
pared favorably to the natural history of oxygen depen-
dence and untreated AAA disease.
In conclusion, it is reasonable to continue to offer AAA
repair to home oxygen–dependent COPD patients who are
ambulatory and medically optimized and who are without
untreated coronary artery disease. Although EVAR may be
the most suitable treatment for oxygen-dependent COPD
patients, our results show that even open repair may be safely
performed in this population, with acceptable results. 24
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